Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical Infectious Diseases

• Publication date

  2008-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/587656PMID 18419481
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Results of a phase Iii trial comparing tolevamer, vancomycin and metronidazole in patients with Clostridium difficile-associated diarrhoea

  2008cited by this paper
• Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.

  2007cited by this paper
• Outcomes of Clostridium difficile-Associated Disease Treated With Metronidazole or Vancomycin Before and After the Emergence of NAP1/027

  2007cited by this paper
• Increase in Clostridium difficile–related Mortality Rates, United States, 1999–2004

  2007cited by this paper
• Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe.

  2007cited by this paper
• A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

  2007influential reference
• A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec.

  2007cited by this paper
• In Vitro Susceptibility of Clostridium difficile Clinical Isolates from a Multi-Institutional Outbreak in Southern Québec, Canada

  2006cited by this paper
• Molecular Analysis of Clostridium difficile PCR Ribotype 027 Isolates from Eastern and Western Canada

  2006cited by this paper
• Antimicrobial Susceptibility Pattern of Clostridium difficile and Its Relation to PCR Ribotypes in a Swedish University Hospital

  2006cited by this paper
• Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–2003

  2006cited by this paper
• In Vitro Activity of Ramoplanin against Clostridium difficile, Including Strains with Reduced Susceptibility to Vancomycin or with Resistance to Metronidazole

  2005cited by this paper
• A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

  2005cited by this paper
• Guidelines for the Diagnosis and Management of Clostridium dfficile-Associated Diarrhea and Colitis

  2005cited by this paper
• Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.

  2005cited by this paper
• Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.

  2005cited by this paper
• Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec

  2005cited by this paper
• Failure to Develop Vancomycin-Resistant Enterococcus With Oral Vancomycin Treatment of Clostridium difficile

  2004cited by this paper
• Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

  2004cited by this paper
• Colonization and Infection With Multiple Nosocomial Pathogens Among Patients Colonized With Vancomycin-Resistant Enterococcus

  2003cited by this paper
• Antecedent Treatment with Different Antibiotic Agents as a Risk Factor for Vancomycin-Resistant Enterococcus

  2002cited by this paper
• The Commonality of Risk Factors for Nosocomial Colonization and Infection with Antimicrobial-Resistant Staphylococcus aureus, Enterococcus, Gram-Negative Bacilli, Clostridium difficile, and Candida

  2002cited by this paper
• Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

  2000influential reference
• The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis.

  1999cited by this paper
• Clostridium difficile-associated diarrhea and colitis.

  1999cited by this paper
• Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest.

  1999cited by this paper
• Mycobacterium xenopi infection in patients with human immunodeficiency virus infection.

  1997cited by this paper
• Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee.

  1997cited by this paper
• Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?

  1997influential reference
• Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.

  1996cited by this paper
• Recommendations for Preventing the Spread of Vancomycin Resistance

  1995cited by this paper
• Clostridium Difficile-Associated Diarrhea and Colitis

  1995cited by this paper
• Recommendations for Preventing the Spread of Vancomycin Resistance

  1995cited by this paper
• Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).

  1995cited by this paper
• Treatment of Asymptomatic Clostridium difficile Carriers (Fecal Excretors) with Vancomycin or Metronidazole

  1992cited by this paper
• Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile.

  1986cited by this paper
• Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.

  1983cited by this paper
• The Influence of Oral versus Parenteral Preoperative Metronidazole on Sepsis Following Colon Surgery

  1980cited by this paper
• Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

  1978cited by this paper
• Oral vancomycin for antibiotic-associated pseudomembranous colitis.

  1978cited by this paper
• Metronidazole for antibiotic-associated pseudomembraneous colitis.

  1978cited by this paper
• Treatment of antibiotic-induced colitis by metronidazole.

  1978cited by this paper
• Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.

  1978cited by this paper
• Hospitals in Switzerland.

  1948cited by this paper

• Antimicrobial Efficacy Evaluations of Metronidazole against Clostridioides difficile Infection using Fecal Pharmacokinetic and Pharmacodynamic Analyses

  2023cites this paper
• Optimal therapeutic recommendation for Clostridioides difficile infection in pediatric and adolescent populations: a systematic review and meta-analysis

  2023cites this paper
• A comparative analysis of gut microbial dysbiosis by select antibiotics and DSS to understand the effects of perturbation on the host immunity and metabolism.

  2022cites this paper
• Economic burden and cost-effectiveness of therapies for Clostridiodes difficile infection: a narrative review

  2021cites this paper
• Effects of treatment with three antibiotics, vancomycin, neomycin, and AVNM on gut microbiome in C57BL/6 mice

  2021cites this paper
• Comparative analysis of beneficial effects of vancomycin treatment on Th1‐ and Th2‐biased mice and the role of gut microbiota

  2020cites this paper
• Effects of gut microbiota perturbation on Th1- and Th2-biased mice following treatment with Vancomycin

  2019cites this paper
• Does oral vancomycin prophylaxis during systemic antibiotic exposure prevent Clostridioides difficile infection relapses? Still in search of an answer

  2019cites this paper
• Critical insights into antibiotic resistance transferability in probiotic Lactobacillus.

  2019cites this paper
• Preserved Efficacy of Oral Metronidazole for Severe Clostridium difficile Infection

  2018cites this paper
• Cationic Amphiphilic Bolaamphiphile-based Delivery of Antisense Oligonucleotides Provides a Potentially Microbiome Sparing Treatment for C. difficile

  2018cites this paper
• Antibiotic exposure Increased patient age Prior hospitalization Severity of underlying illness Proton pump inhibitors and H 2 blocker use Abdominal operation Nasogastric tube Long duration of hospitalization Long-term care residency IBD Organ transplantation Chemotherapy Chronic kidney disease

  2017cites this paper
• Chemical Genomics, Structure Elucidation, and in Vivo Studies of the Marine-Derived Anticlostridial Ecteinamycin.

  2017cites this paper
• Clostridium difficile disease: Diagnosis, pathogenesis, and treatment update.

  2017cites this paper
• Consenso chileno de prevención, diagnóstico y tratamiento de la diarrea asociada a Clostridium difficile

  2016cites this paper
• Diagnosis and Treatment of Clostridium difficile Infection

  2016cites this paper
• Clostridium difficile colonization and antibiotics response in PolyFermS continuous model mimicking elderly intestinal fermentation

  2016cites this paper
• [Chilean consensus of prevention, diagnosis and treatment of Clostridium difficile-associated diarrhea].

  2016cites this paper
• ‘Get in Early’; Biofilm and Wax Moth (Galleria mellonella) Models Reveal New Insights into the Therapeutic Potential of Clostridium difficile Bacteriophages

  2016cites this paper
• Clostridium difficile Infection: An Emerging Cause of Death in the Twenty-First Century

  2016cites this paper
• Fulminant Pseudomembranous Colitis Presenting as Sigmoid Stricture and Severe Polyposis with Clinical Response to Intracolonic Vancomycin

  2016cites this paper
• Mode of Action and Bactericidal Properties of Surotomycin against Growing and Nongrowing Clostridium difficile

  2015cites this paper
• Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo

  2015cites this paper
• Gastrointestinal localization of metronidazole by a lactobacilli-inspired tetramic acid motif improves treatment outcomes in the hamster model of Clostridium difficile infection.

  2015cites this paper
• Fecal microbiota transplantation in gastrointestinal diseases: what practicing physicians should know.

  2015cites this paper
• Mode of Action and Bactericidal Properties of Surotomycin against Growing and Nongrowing Clostridium difficile

  2015cites this paper
• Treatment of Clostridium difficile infections.

  2015cites this paper
• Clostridium difficile infection : the role of antibiotics in outbreak control, epidemiology and treatment

  2014influential citation
• Antibiotics for the therapy of gastrointestinal diseases

  2014cites this paper
• Clostridium-difficile-assoziierte Kolitis

  2014cites this paper
• Topological Data Analysis of DNA sequence data in human gut microbiome

  2014cites this paper
• Clostridium difficile infection in children: a comprehensive review

  2013cites this paper
• The Role of Vancomycin and Metronidazole for the Treatment of Clostridium difficile–Associated Diarrhea

  2013influential citation
• Diarrhea in solid-organ transplant recipients: a review of the evidence

  2013cites this paper
• Markers of Intestinal In fl ammation , Not Bacterial Burden , Correlate With Clinical Outcomes in Clostridium dif fi cile Infection

  2013cites this paper
• Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.

  2013cites this paper
• Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.

  2013cites this paper
• New developments in chemotherapeutic options for Clostridium difficile colitis

  2013cites this paper
• Progress in the Discovery of Treatments for C. difficile Infection: A Clinical and Medicinal Chemistry Review

  2013cites this paper
• Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.

  2013cites this paper
• Diagnosis and management of Clostridium difficile infection.

  2013cites this paper
• Treatment Strategies for Recurrent Clostridium difficile Infection.

  2013cites this paper
• PERSPECTIVES IN CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Diagnosis and Management of Clostridium difficile Infection

  2013cites this paper
• Comparisons Of Patients With Recurrent Vs. Incident-Only Clostridium Difficile-Associated Diarrhea: A Case-Control Study Of Treatment Effectiveness At Yale New Haven Hospital, 2010-2011

  2013cites this paper
• Evaluating patient susceptibility in Clostridium difficile infection

  2013cites this paper
• Clostridium-difficile-Infektionen (CDI) im Wandel der Zeit – ein Thema nur für den Internisten?

  2013cites this paper
• Successful Fecal Transplantation by Enema for Recurrent and Refractory Clostridium difficile Infection

  2013cites this paper
• Systemic antibody responses induced by a two component C. difficile 1 toxoid vaccine protect against C. difficile-associated disease in hamsters 2 3

  2013cites this paper
• Isolation and Characterisation of Temperate Bacteriophages of the Hypervirulent Clostridium difficile 027 Strains

  2013cites this paper
• Antimicrobial activity of LFF 571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008 : clinical and therapeutic implications

  2013cites this paper
• Complications at the time of transcatheter aortic valve implantation.

  2012cites this paper
• MAPK-Activated Protein Kinase 2 Contributes to Clostridium difficile-Associated Inflammation

  2012cites this paper
• Clostridium-difficile-assoziierte Kolitis

  2012cites this paper
• A Real‐World Evaluation of Oral Vancomycin for Severe Clostridium difficile Infection: Implications for Antibiotic Stewardship Programs

  2012cites this paper
• Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital‐Onset Clostridium difficile Infection: Implications for Antimicrobial Stewardship

  2012cites this paper
• Clostridium difficile: expression of virulence factors, resistance to disinfectants and interactions with human cells

  2012cites this paper
• Clostridium-difficile-assoziierte Kolitis

  2012cites this paper
• Vancomycin or Metronidazole for Treatment of Clostridium difficile Infection: Clinical and Economic Analyses

  2011cites this paper
• Comparative Effectiveness of Clostridium difficile Treatments

  2011cites this paper
• Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner.

  2011cites this paper
• Treatment of refractory and recurrent Clostridium difficile infection

  2011cites this paper
• Systemic Absorption from Oral Vancomycin: Check the Dose!

  2011cites this paper
• Controversies in Antimicrobial Stewardship

  2011cites this paper
• Clostridium difficile infection: epidemiology, risk factors and management

  2011cites this paper
• Impact of Clostridium difficile on inflammatory bowel

  2010cites this paper
• Increase in Use of Vancomycin for Clostridium difficile Infection in US Hospitals

  2010cites this paper
• Treatment of antibiotic-associated diarrhea caused by Clostridium difficile

  2010cites this paper
• Impact of Clostridium difficile on inflammatory bowel disease

  2010cites this paper
• Success of self-administered home fecal transplantation for chronic Clostridium difficile infection.

  2010cites this paper
• Evaluation of BD GeneOhm CDiff PCR assay for diagnosis of toxigenic Clostridium difficile infection.

  2010cites this paper
• Demonstration of Conjugative Transposon (Tn5397)-Mediated Horizontal Gene Transfer between Clostridium difficile and Enterococcus faecalis

  2010cites this paper
• BRIEF COMMUNICATION Success of Self-Administered Home Fecal Transplantation for Chronic Clostridium difficile Infection

  2010cites this paper
• Clostridium difficile: an update for the primary care clinician.

  2010cites this paper
• Clostridium Difficile Infection in the “Oldest” Old: Clinical Outcomes in Patients Aged 80 and Older

  2009cites this paper
• Enfermedad asociada a Clostridium difficile en América Latina

  2009cites this paper
• Treatment of Clostridium difficile infection in older adults

  2009cites this paper
• Management of Clostridium difficile Infection : Survey of Practices and Compliance with National Guidelines

  2009cites this paper
• Transcatheter aortic valve implantation : tips and tricks to avoid failure

  2009cites this paper
• Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model.

  2009cites this paper
• Fatal Clostridium difficile enteritis caused by the BI/NAP1/027 strain: a case series of ileal C. difficile infections.

  2009cites this paper
• Management of Clostridium difficile Infection: Survey of Practices and Compliance with National Guidelines Among Primary Care Physicians

  2009cites this paper
• Postdischarge Surveillance System for Nontuberculous Mycobacterial Infection at a Brazilian Regional Referral Hospital After an Outbreak

  2009cites this paper
• Clostridium difficile colitis.

  2009cites this paper
• [Clostridum difficile associated disease in Latin America].

  2009cites this paper
• Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study.

  2009cites this paper
• Management of Clostridium difficile infection--medical or surgical?

  2008cites this paper
• Clostridium difficile Infection ( CDI ) in the Course of Time – An Issue Only for the Internist ?

  year unknowncites this paper
• Vancomycin and Rifaximin Combination Therapy for Diarrhoea Predominant Irritable Bowel Syndrome: An Observational Study

  year unknowncites this paper